Private Investments V. Lp OrbiMed, Director at ProNAi Therapeutics Inc (DNAI), bought 1,989,949 shares at $17.00 ($3.4M) on 2015-07-21, disclosed to the SEC on 2015-07-21.
Open-market purchase of $3.4M DNAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,725,790 | $0 | 0.0% |
| 2 | $5.22 | 89,159 | $465K | 13.5% |
| 3 | $17.00 | 175,000 | $3.0M | 86.5% |
| Total | $1.73 avg | 1,989,949 | $3.4M | 100% |